2,652 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by Keeler Thomas Management LLC

Keeler Thomas Management LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,652 shares of the company's stock, valued at approximately $797,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. MML Investors Services LLC increased its stake in shares of HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company's stock worth $7,241,000 after acquiring an additional 4,285 shares during the period. Meritage Group LP purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth about $18,044,000. Alpha DNA Investment Management LLC purchased a new position in HCA Healthcare during the third quarter valued at approximately $869,000. Finally, NRI Wealth Management LC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $2,896,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 4.7 %

HCA Healthcare stock traded down $15.16 during midday trading on Friday, hitting $305.79. 3,469,113 shares of the stock were exchanged, compared to its average volume of 1,740,103. The stock has a market capitalization of $75.94 billion, a price-to-earnings ratio of 13.92, a PEG ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock's 50-day simple moving average is $315.11 and its 200 day simple moving average is $349.91.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm posted $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.94%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare's payout ratio is presently 13.11%.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on HCA. Wells Fargo & Company lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and dropped their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.